Arteris, INC Form 4 insider transactions

Nicholas B. Hawkins, CFO of Arteris, Inc., sold 690 shares of common stock at a price of $8.17 per share on March 6, 2025, under a pre-arranged 10b5-1 trading plan.

Arteris, Inc. CEO Charles Janac sold 1,973 shares of common stock at $8.19 per share on March 5, 2025, under a pre-arranged 10b5-1 trading plan.

Chief Operating Officer Laurent R. Moll of Arteris, Inc. reports selling 193 shares of common stock at $8.19 per share on March 5, 2025, under a pre-arranged 10b5-1 trading plan.

Paul L. Alpern, VP and General Counsel of Arteris, Inc., sold 406 shares of common stock at $8.17 per share on March 6, 2025, according to a Form 4 filing.

Nicholas Hawkins, CFO of Arteris, Inc., sold shares of common stock on March 3, 2025, to cover tax liabilities and under a pre-arranged 10b5-1 trading plan.

Arteris, Inc. CEO Charles Janac sold 1,330 shares of common stock on March 3, 2025, to cover tax liabilities related to the release of restricted stock units.

Laurent R. Moll, Chief Operating Officer of Arteris, Inc., sold 654 shares of common stock on March 3, 2025, to cover tax liabilities arising from the release of restricted stock units.

Paul Alpern, VP and General Counsel of Arteris, Inc., sold 276 shares of common stock on March 3, 2025, to cover tax liabilities arising from the release of restricted stock units.

Chief Operating Officer Moll Laurent R. reports acquisition of common stock and stock options in Arteris, Inc.

Paul Alpern, VP and General Counsel of Arteris, Inc., reports the acquisition of restricted stock units and stock options.

Nicholas B. Hawkins, VP and CFO of Arteris, Inc., reports the acquisition of stock and options in the company.

Charles Janac, CEO of Arteris, Inc., reports acquisition of restricted stock units and stock options, as well as gifts of common stock.

Director Antonio J. Viana sold 2,491 shares of Arteris, Inc. common stock at an average price of $10.3324, pursuant to a pre-arranged 10b5-1 trading plan.

Nicholas Hawkins, CFO of Arteris, Inc., sold 11,000 shares of common stock at an average price of $10.3292 on February 3, 2025, according to a Form 4 filing.

Arteris, Inc. CEO Charles Janac sold 50,000 shares of common stock on February 3, 2025, at a weighted average price of $10.3295 per share, pursuant to a pre-arranged 10b5-1 trading plan.

Arteris director Saiyed Atiq Raza sold 2,776 shares of common stock at an average price of $12.3366 per share on January 6, 2025, under a pre-arranged 10b5-1 trading plan.

Paul Alpern, VP and General Counsel of Arteris Inc., sold 3,326 shares of common stock at an average price of $12.3484 per share, as part of a pre-arranged 10b5-1 trading plan.

Arteris Inc.'s Chief Operating Officer, Laurent R. Moll, sold 1,161 shares of common stock at $12.52 per share on January 6, 2025, under a pre-arranged 10b5-1 trading plan.

Arteris Inc.'s CFO, Nicholas B. Hawkins, sold 4,560 shares of common stock at an average price of $12.3394 per share on January 6, 2025, under a pre-arranged 10b5-1 trading plan.

Arteris Inc.'s CEO, Charles Janac, sold 8,432 shares of common stock at an average price of $12.3382 per share under a pre-arranged 10b5-1 trading plan and corrected a previous reporting error.

Director Joachim Kunkel acquired 1,514 shares of Arteris, Inc. common stock on January 5, 2025, as compensation in lieu of cash.

Director Antonio J. Viana acquired 2,040 shares of Arteris, Inc. common stock on January 5, 2025, as compensation in lieu of cash.

Wayne C. Cantwell, a director at Arteris, Inc., sold 10,000 shares of common stock over two days under a pre-arranged 10b5-1 trading plan.

Director Saiyed Atiq Raza sold 3,025 shares of Arteris, Inc. common stock at an average price of $10.1553 on January 2, 2025, under a pre-arranged 10b5-1 trading plan.

Arteris CEO, Charles Janac, sold shares to cover tax liabilities and under a pre-arranged 10b5-1 trading plan.

Paul Alpern, VP and General Counsel at Arteris Inc., sold a portion of his common stock to cover tax liabilities arising from the vesting of restricted stock units.

Arteris CFO Nicholas Hawkins sold a total of 14,387 shares of common stock on January 2, 2025, to cover tax liabilities and under a pre-arranged 10b5-1 trading plan.

Arteris Inc.'s Chief Operating Officer, Laurent R. Moll, sold a total of 39,831 shares of common stock in multiple transactions on January 2nd and 3rd, 2025, under a pre-arranged 10b5-1 trading plan.

Arteris CEO Charles Janac sold a total of 71,109 shares of common stock in two transactions on December 30 and 31, 2024, under a pre-arranged 10b5-1 trading plan.

Arteris CEO Charles Janac sold a total of 116,325 shares of common stock over two days under a pre-arranged 10b5-1 trading plan.